(Q40587819)

21 September 2017

Differential effects of raloxifene and estrogen on insulin sensitivity in postmenopausal women (English)

1 reference

21 September 2017

Cathy C Lee

1

1 reference

21 September 2017

Josephine Z Kasa-Vubu

series ordinal

2

1 reference

21 September 2017

Mark A Supiano

series ordinal

3

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Journal of the American Geriatrics Society

21 September 2017

1 reference

21 September 2017

51

1 reference

21 September 2017

5

1 reference

21 September 2017

683-688

1 reference

Clinical effects of raloxifene hydrochloride in women

21 September 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

Some effects of in vivo administered estrogens on glucose metabolism and adrenal cortical secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Role of ovarian hormones in the long-term control of glucose homeostasis. Effects of insulin secretion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

The effect of estrogens on carbohydrate metabolism: glucose, insulin, and growth hormone studies on one hundred and seventy-one women ingesting Premarin, mestranol, and ethinyl estradiol for six months.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Raloxifene provides an alternative for osteoporosis prevention

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Reproducibility of insulin sensitivity measured by the minimal model method.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Effects of the selective estrogen receptor modulator, raloxifene, on the somatotropic axis and insulin-glucose homeostasis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Sex-hormone-binding globulin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

Molecular determinants of tissue selectivity in estrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0579.2003.00214.X

7 January 2021

10.1034/J.1600-0579.2003.00214.X

Identifiers

DOI

1 reference

21 September 2017

1 reference